(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 21.98% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 9.93%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.31%.
Airsculpt Technologies's revenue in 2023 is $165,646,000.On average, 4 Wall Street analysts forecast AIRS's revenue for 2023 to be $12,403,831,229, with the lowest AIRS revenue forecast at $11,950,182,547, and the highest AIRS revenue forecast at $12,796,083,427. On average, 4 Wall Street analysts forecast AIRS's revenue for 2024 to be $14,512,432,545, with the lowest AIRS revenue forecast at $13,956,606,182, and the highest AIRS revenue forecast at $14,902,550,189.
In 2025, AIRS is forecast to generate $16,994,131,253 in revenue, with the lowest revenue forecast at $16,627,044,312 and the highest revenue forecast at $17,361,218,194.